Leuprolide acetate (30-mg depot every four months) in the treatment of advanced prostate cancer
- 1 February 1998
- Vol. 51 (2) , 271-276
- https://doi.org/10.1016/s0090-4295(97)00500-1
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Leuprolide acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancerClinical Therapeutics, 1996
- LeuprorelinDrugs, 1994
- Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate CancerJournal of Urology, 1990